Home    Products    Suboxone Lawsuit

WINDER LAW FIRM

Suboxone Lawsuit

Individuals have filed Suboxone lawsuits, alleging that the drug is linked to severe tooth decay and other dental problems.

Lawsuits claim that companies involved with Suboxone film failed to adequately warn patients and healthcare providers of this significant risk. Individual lawsuits against Suboxone from across the United States have been merged into a Multidistrict Litigation (MDL).

Have you experienced severe dental side effects after taking Suboxone? Request a free case evaluation to discuss your situation and potential legal options.

No Upfront Legal Fees

Free, Confidential Case Review

Replies Within 1 Business Day

Virtual Consultations Available

2026 Suboxone Lawsuit Update

We keep track of the case so you don’t have to

Key Takeaways

  • The Suboxone lawsuit alleges the drug is associated with severe dental issues. Plaintiffs argue that the makers failed to warn users about these risks.
  • Individual Suboxone dental lawsuits from across the United States have been consolidated into Multidistrict Litigation (MDL 3092). This MDL is being handled in the U.S. District Court for the Northern District of Ohio.
  • Studies and FDA reports have been cited in support of dental damage claims.

Recent Suboxone lawsuit updates

June 1st, 2026 - June 2026 JPML Update

The Suboxone MDL added 1 case between May and June, increasing from 1,832 to 1,833.

The docket remained largely unchanged during a month focused on expert discovery and case-specific proceedings involving allegations that Suboxone’s formulation caused severe tooth decay and dental injuries.

While new filings have slowed considerably, the litigation continues to advance toward later-stage pretrial proceedings as the parties develop evidence on causation and damages.

May 1, 2026 - May JPML Update

The Suboxone MDL dropped by 4 cases in May, from 1,836 to 1,832.

The court also addressed Schedule A plaintiffs who used shorter filings before deadline issues arose. Those plaintiffs must now file their cases or risk being dismissed.

View Complete Suboxone Litigation Timeline

This Lawsuit Is Active

See If You Qualify icon

Introduction to the Suboxone Lawsuit

The Suboxone lawsuit involves claims from individuals who had severe dental issues after taking the drug. They claim the makers failed to provide adequate warnings about dental risks.

What is Suboxone?

Suboxone is a prescription medicine used for maintaining opioid dependence treatment.

Suboxone combines two active ingredients: buprenorphine and naloxone. Buprenorphine lessens the withdrawal symptoms and cravings. Naloxone is a deterrent to abusing opioids. The combo treats opioid dependence and misuse. Suboxone was approved by the FDA in 2002.

Suboxone can be part of a complete treatment plan, including counseling and support.

Overview of Claims Against Manufacturers

The essence of the Suboxone lawsuit claims that companies involved with Suboxone film didn’t warn about risks. The specific alleged risk is severe dental decay, among other problems. Plaintiffs allege the companies prioritized sales over adequate disclosure of dental risks.

Other legal claims include deceptive marketing and violations of consumer protection laws. Claims say the companies used misleading ads. The claims also say the companies didn’t share important information on Suboxone’s side effects. The claims say these practices put patients’ health at risk.

Suboxone Lawsuit Overview

Major Claims in the Suboxone Litigation

Lawsuits allege that Suboxone film contributed to serious dental issues. They cite case reports and expert statements in support of their allegations. Some researchers have suggested that the acidic nature of Suboxone may contribute to dental harm, though further study is needed.

The FDA also states that buprenorphine remains an important treatment option, and patients should not stop taking it without speaking to a healthcare provider.

Description of Dental Health Claims

Patients have reported dental issues during Suboxone treatment, according to FDA adverse event data. Some of these include:

  • Cavities
  • Tooth loss
  • Enamel erosion

Many users required extensive dental treatments, including root canals, crowns, extractions, and treatment for enamel loss and oral infections.

Is there a Suboxone Class Action Lawsuit?

There is currently no Suboxone class action lawsuit. Many people wonder if the Suboxone lawsuits are part of a class action. These cases are not being handled as a class action lawsuit. Instead, they are part of a Multidistrict Litigation (MDL) in Ohio. MDLs merge individual lawsuits for more efficient pretrial proceedings.

Details on Multidistrict Litigation (MDL)

The individual Suboxone cases are now managed through a multidistrict litigation (MDL). This process brings together individual lawsuits with similar issues. This allows for streamlining of pretrial matters. The MDL allows for organized discovery and consistent rulings on common legal questions.

Unlike a class action, each plaintiff in an MDL maintains an individual lawsuit. This allows individuals to receive a personalized resolution based on their specific situations.

Suboxone Side Effects & Tooth Decay

Suboxone has been the subject of legal claims alleging it contributes to dental issues. This includes tooth decay, cavities, tooth loss, and enamel erosion. Some research and FDA reports have described adverse dental events in Suboxone users. 

Medical Disclaimer: This content is for informational purposes only and is not medical advice. Consult your doctor about any health concerns.

Evidence Supporting Tooth Decay Claims

Several studies and case reports have been cited in claims linking Suboxone use to tooth decay. Key findings include:

  • Harvard Medical School Case Report (2012). This report described a patient with severe dental decay following long-term Suboxone use. The authors noted a possible association but did not assess causation.
  • Brigham and Women’s Hospital Case Series (2013). Researchers noted 11 patients with opioid dependence who suffered from worsening dental health after starting buprenorphine treatment. Issues included cavities, cracked teeth, and the need for root canals or extractions.
  • FDA Reports. FDA adverse event reports have included dental complaints involving Suboxone sublingual film.

These studies have been cited in lawsuits alleging a link between Suboxone use and dental damage.

Manufacturer Stated Side Effects

The maker of Suboxone, Indivior, lists several side effects that patients should be aware of. Of course, most attention is given to the possibility of abuse and withdrawal symptoms, but there are others listed as well. According to the Suboxone website, these side effects are reported to include:

  • Trouble breathing
  • Sleepiness, dizziness, coordination problems
  • Physical dependence or abuse
  • Liver problems (jaundice, dark urine, light stools, loss of appetite, stomach pain, nausea)
  • Allergic reactions (rash, swelling, wheezing, low blood pressure, loss of consciousness)
  • Opioid withdrawal (shaking, sweating, temperature sensitivity, runny nose, watery eyes, goosebumps, diarrhea, vomiting, muscle aches)
  • Decrease in blood pressure (dizziness on standing)
  • Headache 
  • Nausea and vomiting 
  • Constipation
  • Pain
  • Increased sweating
  • Insomnia
  • Potential fertility effects in males and females.

Patients should consult their healthcare provider if they experience any dental issues while on the medication.

Do you experience any of the symptoms above?

Let’s discuss your legal options in a free case review. Information-mark-

See If You Qualify

Key Legal Proceedings and Milestones

The Suboxone Multidistrict Litigation (MDL) has seen several significant milestones. These events highlight the progress of the litigation, from the merging of cases to key filings and rulings.

April 1, 2026 – April Suboxone Filing Update

The JPML count for the Suboxone MDL dropped from 1,849 cases in March to 1,836 in April. The case remains about claims that Suboxone led to severe dental injuries, such as tooth decay, tooth loss, and oral infections.

January 22, 2026 – Court Reviews Discovery Issues

The court held a case-management meeting to check the status of discovery in the Suboxone MDL. Much of the talk focused on medical records, census forms, and document issues from both sides. The judge also warned that third parties that fail to produce required records could face contempt.

January 5, 2026 – January JPML Filing Update

The January JPML report showed fewer Suboxone cases on the MDL docket. The count went from 1,871 pending cases in December to 1,854 in January. That is a drop of 17 cases, which points more to normal docket clean-up than a change in the core claims.

December 2, 2025 – Suboxone Case Count Holds Steady

The Suboxone tooth decay MDL stayed at 1,871 cases in December, with no new filings reported by JPML. The case still focuses on claims that Suboxone film damaged users’ teeth after long-term use. Plaintiffs say the product label failed to warn about the film’s acidic nature and dental risks.

November 26, 2025 – Judge Gets Suboxone Case Update

Lawyers returned to court on November 21, 2025, for a status update in the Suboxone tooth decay MDL. Judge J. Philip Calabrese is handling the case in the Northern District of Ohio. By this point, more than 5,700 active claims were before the court. The claims focus on Indivior’s film product. Plaintiffs also allege Indivior and Reckitt Benckiser did not warn users soon enough, before the FDA added a dental warning in June 2022.

November 3, 2025 – Suboxone MDL Sees Small Filing Drop

Suboxone filings dipped in the November JPML report. The MDL went from 1,887 cases to 1,871. Plaintiffs allege that Suboxone film led to tooth decay, erosion, and tooth loss. They also claim Indivior failed to warn consumers about those risks. The case remains in discovery.

October 14, 2025 – Judge Updates Suboxone MDL Rules

Judge J. Philip Calabrese set new census form rules for the Suboxone MDL. Cases filed after October 1, 2025, must include census forms within 60 days. Older cases have until June 1, 2026.

October 1, 2025 – October Suboxone Filing Update

Active Suboxone MDL cases fell from 1,887 in September to 1,882 in October. The small drop did not end the case. Plaintiffs continue to claim long-term Suboxone use led to serious dental harm.

September 2, 2025 – September JPML Update

The Suboxone MDL grew from 889 cases in August to 1,882 in September. The lawsuits claim Suboxone caused tooth decay, enamel loss, and other dental harm. Plaintiffs also claim the maker failed to give proper warnings.

August 1, 2025 – Suboxone MDL Filing Update

The JPML reported a slight change in the Suboxone tooth decay MDL, with filings dropping from 890 to 889. Plaintiffs still claim Suboxone’s acidic film led to tooth decay and tooth loss. The court is also reviewing pretrial scheduling and early discovery issues.

July 31, 2025 – Suboxone MDL Uses Block Filing System

The Suboxone tooth decay MDL has grown to more than 11,000 cases in Ohio federal court. Plaintiffs claim Suboxone film caused tooth decay, gum disease, enamel loss, and tooth loss. They also claim Indivior failed to warn users about these risks before the label was changed in June 2022. Judge J. Philip Calabrese issued an order that lets up to 100 people file together in one complaint. The court has also allowed failure-to-warn claims to move ahead while narrowing some design defect claims. Bellwether trials are expected in late 2025 or early 2026.

July 21, 2025 – Suboxone MDL Moves Through Discovery

Judge J. Philip Calabrese addressed discovery and case management issues during the latest Suboxone MDL status conference. The parties agreed on redacted deposition transcripts, standard medical release forms, and a process for tracking claims filed after October 7, 2024. The court also discussed how documents from key people in the case will be collected. Judge Calabrese resolved two disputes over Rule 30(b)(6) deposition notices and told both sides to keep working through one remaining document issue. Deadlines were set for a non-custodial document plan and fact sheets from each side. An in-person hearing was scheduled for September 9, 2025.

July 15, 2025 – Suboxone MDL Leadership Stays in Place

On July 14, 2025, Judge J. Philip Calabrese reappointed the lead lawyers in the Suboxone tooth decay MDL. The case is in federal court in the Northern District of Ohio. The lead team will keep handling key court tasks. This includes records, case steps, and work tied to the first trial picks. The court also had a case meeting set for July 15, 2025. One main topic was the bellwether plan. Bellwether trials are early test trials. They help both sides see how the proof and claims could be viewed in court. The court had set up a pool of 500 cases for record review. A smaller group would then move into deeper case work. After that, a few cases could be picked for early trials. The lawsuits claim Suboxone film caused severe tooth harm and that users were not warned soon enough.

June 2, 2025 – Case Count Drops Slightly

The total number of Suboxone lawsuits in the MDL fell from 896 to 892. Attorneys are awaiting key rulings on expert testimony, also known as Daubert motions.

May 22, 2025 – 50 Bellwether Cases Selected

The court selected 50 cases for focused discovery. These may go to trial first and help shape future settlements.

Settlement Disclaimer: Past outcomes don’t predict future results. Each case is different.

April 7, 2025 – Lawsuit Deadline Approaching

The court set a June 17, 2025, deadline for key medical authorizations, which aligns with the statute of limitations in many states.

March 3, 2025 – Judge Orders Faster Record Access

A federal judge ordered dentists and doctors to release patient records more efficiently, thereby facilitating the progress of lawsuits.

January 7, 2025 – Claims Narrowed But Move Forward

The judge allowed failure-to-warn claims against Indivior Inc. to proceed and allowed some pre-approval design defect claims to move forward, while narrowing post-approval design defect claims.

November 22, 2024 – Direct Filing Allowed in MDL

Plaintiffs are now permitted to file Suboxone lawsuits directly in the federal MDL court, making the process more streamlined.

November 21, 2024 – Suboxone Found to Be Highly Acidic

A study reported that Suboxone’s acidic pH may impact dental health, but it did not establish a proven cause of tooth decay.

November 18, 2024 – Suboxone Users More Likely to Have Dental Issues

One study found more reported dental problems in Suboxone film users than in users of other opioid treatments. However, no causal relationship was proven.

July 11, 2024 – Potential Tolling Agreement in Suboxone Lawsuit

The Suboxone lawsuit might see a tolling agreement soon. Tolling agreements stop the clock on filing deadlines. This means plaintiffs won’t have to rush to file lawsuits.

May 2024 – Key Updates

May 14: Defense counsel opposed plaintiffs’ tolling discovery proposal, arguing it would lead to poorly probed claims due to record delays.

May 3: The MDL court scheduled a virtual status conference for May 14 and an in-person meeting for June 6 to address protective orders, tolling issues, and procedural motions.

April 2024 – MDL Developments

April 19: Indivior urged the MDL to focus on general causation rather than specific causation.

April 4: MonoSol Rx was dismissed from litigation and is no longer a defendant.

March 2024 – Early Case Management

March 27: Judge issued CMO No. 3 with filing/service procedures.

March 26: Discussions began on the severity of dental injuries required to support claims.

March 19: CMO No. 3 detailed direct filing procedures.

March 12: Defendants filed corporate disclosures.

March 7: Initial status conference held, leadership appointed.

March 5: MDL reached 51 cases with rapid growth expected.

February 2024 – MDL Consolidation

The panel combined 15 Suboxone tooth decay cases into one MDL in Ohio.

January 2024 – Hearing Scheduled

The Judicial Panel on Multidistrict Litigation scheduled a Jan. 25 hearing on consolidating Suboxone tooth decay lawsuits.

December 2023 – MDL Consideration

The panel announced it would decide in Jan. 2024 whether to merge 15 Suboxone cases into one MDL.

November 2023 – Centralization Request

Lawyers requested centralization of federal Suboxone lawsuits. Fourteen new cases were filed in Ohio.

October 2023 – $385 Million Settlement

Indivior agreed to pay $385 million to settle monopoly lawsuits from wholesalers. Past outcomes don’t predict future results.

September 2023 – Individual Lawsuit Filed

David Sorensen sued Indivior and others for alleged tooth damage from Suboxone.

August 2023 – Settlement Agreement

Indivior settled with wholesalers for $385 million. Past outcomes don’t predict future results.

April 2023 – FTC Payments

FTC issued $369,000 in payments to consumers in Suboxone class-action lawsuits who missed deadlines.

January 2022 – FDA Adds Dental Warning

The FDA updated buprenorphine labels, including Suboxone, to warn about dental risks.

Legal Scrutiny Over Suboxone Side Effects

The Science Behind Suboxone and Legal Implications

Suboxone has two primary ingredients, buprenorphine and naloxone. Buprenorphine is what’s called a partial opioid agonist. Buprenorphine reduces withdrawal symptoms by stimulating a person’s opioid receptors but without the full opioid effect. Then, Naloxone, which is an opioid antagonist, blocks the opioid effects. Patients take Suboxone by placing it under their tongues. 

Lawsuits allege that the acidic nature of Suboxone may play a role in dental problems such as enamel erosion and decay. Lawsuits allege that this may contribute to dental problems, including decay. This alleged mechanism is a core part of the legal claims against Suboxone.

Exploring the Ingredients in Suboxone

Suboxone contains two active ingredients:

  • Buprenorphine: This ingredient helps manage opioid dependence by reducing withdrawal symptoms and cravings. Known side effects include dry mouth, which can contribute to dental problems.
  • Naloxone: This ingredient blocks the effects of opioids and helps prevent misuse of Suboxone. While it primarily acts to deter abuse, it does not directly contribute to dental issues.

The focus on these ingredients in the lawsuit centers on buprenorphine’s side effects. This includes dry mouth, which can exacerbate dental decay.

Suboxone Settlement Information

Settlement Disclaimer: Past results do not guarantee future outcomes. Each case is unique, and compensation depends on individual circumstances.

Information on Past Settlements

To date, there have been several settlements related to Suboxone. Specific amounts and terms are not always public. One notable settlement occurred in 2023. Indivior agreed to pay $385 million to resolve lawsuits by drug wholesalers. These lawsuits claimed Indivior illegally suppressed generic competition for Suboxone.

How much will I get from the Suboxone settlement?

There is currently no settlement for Suboxone dental claims. If one is reached, compensation will vary based on individual case facts. The cases are still in the early stages of litigation. The amount you could receive, if any, will depend on future settlements. For now, the litigation is ongoing, with no specific payouts determined.

How to Join the Suboxone Lawsuit in 2025

How to Join the Suboxone Lawsuit

To join the Suboxone lawsuit in 2025, you may consider the following steps:

  1. Contact an attorney. Fill out the form below for a free case evaluation. If eligible, a partner law firm may contact you to discuss your legal options.
  2. Gather Records: Collect proof of your Suboxone prescription and dental records.
  3. File a Claim: You may file independently or with the help of an attorney. Many choose to work with legal counsel to navigate the process.

Criteria for Eligibility

To join the Suboxone lawsuit, you must meet specific criteria:

  • Proof of Suboxone prescription
  • Documented dental issues such as tooth decay, cavities, or tooth loss
  • Medical records documenting your dental issues and history of Suboxone use

What to Expect When Filing a Suboxone Lawsuit

Note: Fill out the form or call to see if legal options may be available. Inquiries will be shared with a partner law firm under a marketing arrangement to assist with next steps.

If your case is accepted, our partner firms may assist you in filing a Suboxone lawsuit. Here’s what to expect:

  1. First Consultation: You start by meeting with your lawyer for a free and confidential case review. The attorney will consider whether your dental issues may be related to Suboxone use.
  2. Case Preparation: Your attorney will assist you in gathering all the necessary documents. This includes medical and dental records, as well as evidence of side effects. 
  3. Navigating the Process: Your attorney will manage the initial filings and oversee the legal processes. You’ll be kept informed throughout the entire process.
  4. Continued Support: Winder Law Firm’s partners will be by your side throughout the process. We provide continuous support and updates.

Typical timelines can vary, but most cases progress through these stages over several months to a few years.

Consult a Suboxone Lawyer Today

If you have suffered dental issues after using Suboxone, fill out the form for a free consultation and case evaluation. Our legal partners can evaluate your claim and, when appropriate, refer you to partner firms for potential representation.

Resources for Tooth Decay Patients

Here are some resources for dental care and patient advocacy:

1. American Dental Association (ADA): ADA website

2. National Institute of Dental and Craniofacial Research (NIDCR): NIDCR website

Legally Reviewed By Aaron Winder
Last Modified: October 3, 2025
Fact Checked
Legally Reviewed
Decorative dot left

Table of Content

Decorative dot right

Related reading


Are you having symptoms from Suboxone?icon

Review My Case For Free

Most Asked Questions

CONTACT US IF YOU STILL HAVE QUESTIONS

Fact Checked

Winder Law Firm strives to provide accurate and timely information, but the content on this page is for informational purposes only and should not be taken as legal advice. If you need legal guidance or are considering legal action, consult an attorney. This website strives to follow applicable state bar and ABA ethical marketing rules. We are not responsible for third-party content, including linked law firms or services, and do not endorse or recommend them. We bear no liability for security risks or issues from external links.

View our editorial guidelines for more details.

Legally Approved

The content on this page has been reviewed for legal accuracy by Attorney Aaron A. Winder. This content is for informational purposes only and not legal advice. It is not a substitute for professional legal counsel. Winder Law Firm does not guarantee this website content’s accuracy, completeness, or relevance. This website may contain inaccuracies, typographical errors, or outdated information and does not necessarily reflect the firm’s or its employees’ opinions. Consult an attorney for legal guidance.

Legally Reviewed

The content on this page has been reviewed for legal accuracy by Attorney Aaron A. Winder. This content is for informational purposes only and not legal advice. It is not a substitute for professional legal counsel. Winder Law Firm does not guarantee this website content’s accuracy, completeness, or relevance. This website may contain inaccuracies, typographical errors, or outdated information and does not necessarily reflect the firm’s or its employees’ opinions. Consult an attorney for legal guidance.

Award Methodology

The CALI Excellence for the Future Award® is given to the highest-scoring student in a law school course, as determined by the instructor or registrar. This award recognizes academic excellence in legal education and is granted by the Center for Computer-Assisted Legal Instruction (CALI), a nonprofit consortium of law schools and organizations.

Attorney Aaron A. Winder, owner of Winder Law Firm, received this award in Advanced Criminal Procedure while studying at Gonzaga University School of Law.

More information about the CALI Excellence for the Future Award® can be found at CALI’s website.

This recognition has not been reviewed or approved by any state supreme court or bar association.

Disclaimer

This page offers general information, not legal advice, and does not create an attorney‑client relationship. Allegations mentioned are unproven in court. Information is based on public sources. Inquiries are shared with a partner firm under a marketing arrangement.